ISEC Healthcare Ltd
SSGX:40T0.31
SGD
+0.02
(+6.90%)
ISIN
SG1AD9000001
Return %
Stock
S&P 500
1Y
-11.43
14.20
3Y
-26.19
81.12
5Y
3.33
68.34
Capital Structure
SGD
•
in mil. unless spec.Working Capital
SGD
•
in mil. unless spec.Growth Rates
SGD
•
in mil. unless spec.Quarterly Revenue
SGD
•
in mil. unless spec.Quarterly Earnings Per Share
SGD
•
in mil. unless spec.Quarterly Dividends Per Share
SGD
•
in mil. unless spec.Company Description
- CEO
- Jun Shyan Wong
- Full Time Employees
- 366
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Singapore Singapore
- IPO Date
- Oct 28, 2014
- Website
- isechealthcare.com
- Similar Companies
- Business
- ISEC Healthcare Ltd. is an investment holding company and comprehensive regional provider of specialized medical eye care and general healthcare services. The company operates through two core business segments: Specialized Health Services and General Health Services. Under its Specialized Health Services segment, the company delivers tertiary and quaternary ophthalmic care through an extensive network of ambulatory surgical centers and specialist clinics operating primarily under the ISEC brand, Southern Specialist Eye Centre, Indah Specialist Eye Centre, and Ipoh Eye Specialist Centre. Its clinical offerings encompass cataract and refractive surgery, including phacoemulsification, femtosecond laser-assisted cataract surgery, premium intraocular lens implantation, LASIK, photorefractive keratectomy, and implantable collamer lens procedures; vitreoretinal disease management, such as pars plana vitrectomy, retinal laser photocoagulation, and anti-vascular endothelial growth factor intravitreal injections for diabetic retinopathy and age-related macular degeneration; corneal and external eye disease treatments, including corneal collagen cross-linking, pterygium excision, and penetrating or lamellar corneal transplantation; glaucoma diagnostics and interventions, comprising medical therapies, selective laser trabeculoplasty, trabeculectomy, and minimally invasive glaucoma surgery; paediatric ophthalmology and adult strabismus correction; uveitis and ocular immunology consultations; neuro-ophthalmic evaluations; oculoplastic, orbital, and reconstructive surgery, alongside facial aesthetics; and optometry and optical dispensary services. Under its General Health Services segment, the group operates general practice clinics under the JL Medical brand, providing outpatient medical consultations, routine health screenings, occupational health examinations, and minor procedural treatments. Tracing its operational origins to 2007 and formally incorporated in 2014, ISEC Healthcare Ltd. is headquartered in Singapore and operates as a subsidiary of Aier Eye International (Singapore) Pte. Ltd., serving private patients, corporate clients, and medical tourists across Singapore, Malaysia, and Myanmar. In recent developments, the group has accelerated its regional clinical network expansion, executing a joint venture agreement to establish specialist operations in Muar, Johor, while securing regulatory licensing and launching newly expanded specialist centers in Sitiawan, Taiping, and Teluk Intan in Perak, alongside clinic expansions in Seremban, Klang, and Kuching. Additionally, the company made unconditional its acquisition of strata-titled property units in Kuala Lumpur for the development of a flagship purpose-built medical center scheduled for operation in 2027, advanced its international presence in Myanmar via the ARYU International Specialist Eye Centre in Yangon, and appointed an Acting Deputy Chief Executive Officer to spearhead ongoing regional growth and strategic integration.